Mary Ellen Vajravelu1,2, Joseph M Kindler3, Babette S Zemel4,5, Abbas Jawad5,6, Dorit Koren7, Preneet Brar8, Lee J Brooks9, Jessica Reiner10, Lorraine E Levitt Katz5,11. 1. Division of Pediatric Endocrinology, Diabetes, and Metabolism, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 2. Center for Pediatric Research in Obesity and Metabolism, UPMC Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA. 3. College of Family and Consumer Sciences, Department of Foods and Nutrition, University of Georgia, Athens, GA, USA. 4. Division of Gastroenterology, Hepatology and Nutrition at The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 5. University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. 6. Division of General Pediatrics, The Children's Hospital of Philadelphia, Philadelphia, PA, USA. 7. Pediatric Endocrine Division, Department of Pediatrics, Massachusetts General Hospital for Children and Harvard Medical School, Boston, MA, USA. 8. Division of Endocrinology and Diabetes, Department of Pediatrics, New York University Grossman School of Medicine, New York, NY, USA. 9. Rowan University School of Osteopathic Medicine, Stratford, NJ, USA. 10. College of Arts and Sciences, University of Pennsylvania, Philadelphia, PA, USA. 11. Division of Endocrinology & Diabetes, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
Abstract
OBJECTIVES: To evaluate the relationships between adipose tissue distribution, insulin secretion and sensitivity, sleep-disordered breathing, and inflammation in obese adolescents. METHODS: Cross-sectional study of 56 obese adolescents who underwent anthropometric measures, dual-energy X-ray absorptiometry, overnight polysomnography, oral glucose tolerance test (OGTT) and frequently sampled intravenous glucose tolerance test. Correlation and regression analyses were used to assess relationships between adiposity, insulin secretion and sensitivity, measures of sleep-disordered breathing (oxyhemoglobin nadir, SpO2; apnea hypopnea index, AHI; arousal index, AI; maximum end-tidal CO2; non-REM sleep duration), and inflammation (high-sensitivity C-reactive protein, hsCRP). RESULTS: Subjects (55% female) were mean (SD) 14.4 (2.1) years, with BMI Z-score of 2.3 (0.4). AHI was >5 in 10 (18%) subjects and 1< AHI ≤5 in 22 (39%). Visceral adipose tissue area (VAT) was positively correlated with OGTT 1 and 2 h insulin and 1 h glucose, and hsCRP (r=0.3-0.5, p≤0.007 for each). VAT was negatively correlated with sensitivity to insulin (r=-0.4, p=0.005) and SpO2 nadir (r=-0.3, p=0.04) but not with other sleep measures. After adjustment for BMI-Z, sex, population ancestry, age, and sleep measures, VAT remained independently associated with insulin measures and 1 h glucose, but no other measures of glycemia. SAT was not associated with measures of glycemia or insulin resistance. CONCLUSIONS: Among adolescents with obesity, visceral adiposity was associated with insulin resistance, SpO2 nadir, and inflammation. The independent association of visceral adiposity with insulin resistance highlights the potential role of VAT in obesity-related chronic disease.
OBJECTIVES: To evaluate the relationships between adipose tissue distribution, insulin secretion and sensitivity, sleep-disordered breathing, and inflammation in obese adolescents. METHODS: Cross-sectional study of 56 obese adolescents who underwent anthropometric measures, dual-energy X-ray absorptiometry, overnight polysomnography, oral glucose tolerance test (OGTT) and frequently sampled intravenous glucose tolerance test. Correlation and regression analyses were used to assess relationships between adiposity, insulin secretion and sensitivity, measures of sleep-disordered breathing (oxyhemoglobin nadir, SpO2; apnea hypopnea index, AHI; arousal index, AI; maximum end-tidal CO2; non-REM sleep duration), and inflammation (high-sensitivity C-reactive protein, hsCRP). RESULTS: Subjects (55% female) were mean (SD) 14.4 (2.1) years, with BMI Z-score of 2.3 (0.4). AHI was >5 in 10 (18%) subjects and 1< AHI ≤5 in 22 (39%). Visceral adipose tissue area (VAT) was positively correlated with OGTT 1 and 2 h insulin and 1 h glucose, and hsCRP (r=0.3-0.5, p≤0.007 for each). VAT was negatively correlated with sensitivity to insulin (r=-0.4, p=0.005) and SpO2 nadir (r=-0.3, p=0.04) but not with other sleep measures. After adjustment for BMI-Z, sex, population ancestry, age, and sleep measures, VAT remained independently associated with insulin measures and 1 h glucose, but no other measures of glycemia. SAT was not associated with measures of glycemia or insulin resistance. CONCLUSIONS: Among adolescents with obesity, visceral adiposity was associated with insulin resistance, SpO2 nadir, and inflammation. The independent association of visceral adiposity with insulin resistance highlights the potential role of VAT in obesity-related chronic disease.
Authors: Mark D Deboer; James P Mendoza; Lei Liu; Gabriele Ford; Pearl L Yu; Benjamin M Gaston Journal: Sleep Breath Date: 2011-03-01 Impact factor: 2.816
Authors: David R Weber; Lorraine E Levitt Katz; Babette S Zemel; Paul R Gallagher; Kathryn M Murphy; Susan M Dumser; Terri H Lipman Journal: Diabetes Res Clin Pract Date: 2014-01-08 Impact factor: 5.602
Authors: Muhammad A Abdul-Ghani; Valeriya Lyssenko; Tiinamaija Tuomi; Ralph A DeFronzo; Leif Groop Journal: Diabetes Care Date: 2008-11-18 Impact factor: 19.112
Authors: Catherine W Yeckel; Ram Weiss; James Dziura; Sara E Taksali; Sylvie Dufour; Tania S Burgert; William V Tamborlane; Sonia Caprio Journal: J Clin Endocrinol Metab Date: 2004-03 Impact factor: 5.958
Authors: Dennis M Styne; Silva A Arslanian; Ellen L Connor; Ismaa Sadaf Farooqi; M Hassan Murad; Janet H Silverstein; Jack A Yanovski Journal: J Clin Endocrinol Metab Date: 2017-03-01 Impact factor: 5.958
Authors: Dorit Koren; Lorraine E Levitt Katz; Preneet C Brar; Paul R Gallagher; Robert I Berkowitz; Lee J Brooks Journal: Diabetes Care Date: 2011-09-20 Impact factor: 17.152